In this study, however, we found that the presence of CENPA did not increase the sensitivity of CA125 or HE4 for predicting ovarian cancer outcomes (compare Figs. S1A and S1B with Figs. 4A and 4B). This evidence concerns the gene WFDC2 and ovarian cancer.